UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: Concerta-36mg-PRTablet-SE-AJ-MPD-BBDL

Concerta 36 mg Depottablett

MPID: SE-100003163-00018542
EURDID: 2024

Full name: Concerta 36 mg Depottablett

- Invented Name Part: Concerta

- Strength part: 36 mg

- Pharmaceutical dose form part: Depottablett

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Prolonged-release tablet

Legal status of supply: Medicinal product subject to special medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000097721 methylphenidate

Marketing Authorisation 1 of 1

Authorisation number: 18542

Region: Kingdom of Sweden

Marketing authorisation holder: Janssen-Cilag AB

Identifier:

  • LOC-100061163

Status: Valid (2002-11-01)

Package 1 of 1

PCID:

Description:
Burk, 30 tabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 30 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 1 Bottle (High Density PolyEthylene)

Containing: 30 Tablet

Manufactured Item

Dose form: Prolonged-release tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Methylphenidate hydrochloride

Presentation strength: 36 milligram(s) / 1 Tablet

Reference strength:
Methylphenidate 31.13 milligram(s) / 1 Tablet

Administrable Product (1 of 1)

Dose form: Prolonged-release tablet

Unit of presentation:

Route of administration:

  • Oral use

Ingredients:

Ingredient

Role: Active

Substance: Methylphenidate hydrochloride

Presentation strength: 36 milligram(s) / 1 Tablet

Reference strength:
Methylphenidate 31.13 milligram(s) / 1 Tablet